Project Grant F32DA067341

The National Institute on Drug Abuse, part of the Department of Health and Human Services National Institutes of Health, awarded The Trustees of Columbia University in the City of New York $172,160 on December 9, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279).

The award funds a postdoctoral fellowship to examine how HIV-specific state legal policies function as barriers to perinatal care and drug use treatment engagement among pregnant women. The research employs a mixed-methods convergent parallel design across two primary aims. Aim 1 involves creating a database of HIV-specific state features across all 50 states and the District of Columbia from 2010 to 2025. Aim 2 examines how pregnant women perceive and are affected by these state characteristics in their care-seeking behavior for both perinatal care and drug treatment, with particular attention to people who use drugs and those experiencing multiply marginalized status. The project addresses rising severe maternal morbidity rates and the increasing prevalence of opioid use disorder diagnosed at delivery, signaling inadequate access to drug treatment care during pregnancy.

Performance occurs in New York, New York. The period of performance extends from December 9, 2026, through August 14, 2029. This is classified as a Project Grant, an assistance type supporting defined research activities.